STELIOS AMERICANOS & CO LLC | View firm profile
THE
MAIN PROVISIONS OF THE LEGISLATION WHICH IS UNDER DISCUSSION BEFORE THE HOUSE
OF THE REPRESENTATIVES FOR THE LEGALISATION OF THE IMPORTATION AND/OR
PRODUCTION AND/OR CULTIVATION OF PHARMACEUTICAL CANNABIS
The purpose of
the proposed legislation is to amend the Drugs and Psychotropic Substances Act
of 1977 to 2016, in order to add additional provisions allowing the regulation
of imports of cannabis and cannabis seeds into the Republic. Moreover, the
Drugs and Psychotropic Substances (Pharmaceutical Cannabis) Regulations of 2017
(“Regulations”) will regulate among others:
(a) the
cultivation, production, importation and exportation of pharmaceutical cannabis
and its use for the conduct of scientific research for medical purposes, for
the preparation of galenical products by pharmacies for medical or
pharmaceutical production,
(b) the free
provision of pharmaceutical cannabis to eligible patients.
Persons
eligible to apply for a License to produce Pharmaceutical Cannabis
In particular,
the draft regulations stipulate that natural persons who should be adults and
have their habitual residence in the Republic or in another State Member State,
as well as legal entities formed under the laws of the Republic or of another
Member State, which have a registered office or place of employment in the
Republic and whose staff and directors are all adults are eligible to apply for
a license.
Moreover, the
potential applicants shall have at
least five years of experience in the cultivation and production of pharmaceutical
cannabis in the world market. The competent authority, will grant the right to file applications for
two Producer licenses. The
said license will be valid for a period of up to 15 years.
For more
information as to this contact Stelios Americanos & Co LLC on the following
emails:
Christoforos.tsekouras@americanoslaw.com or info@americanoslaw.com;